This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Neptune To Hold Conference Call To Discuss First Quarter Results

LAVAL, Quebec, July 9, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. (" Neptune") (Nasdaq:NEPT) (TSX:NTB) will be holding a conference call on Tuesday July 16, at 9:00 am ET to present its results for the first quarter ended May 31, 2013. The Company will also be providing an update on the status of its previously disclosed action plan to resume operations and supply customers.

The conference call hosts will be Henri Harland, President & CEO and André Godin, CFO.

To access the conference call within Canada & the U.S., dial toll-free 1‐877-380-5664. Outside Canada and the U.S., dial 1-631-813-4882.

Conference call details:  
Conference Topic:  Neptune Technologies & Bioressources first quarter ended May 31, 2013 Results Call 
Conference ID:  16440484
Time:  9:00 AM Eastern Time

Management will accept questions related to the financial results and its operations by telephone during the Q&A period at the end of the presentation. Questions can also be forwarded in advance or during the presentation to f.harland@neptunebiotech.com.

An archived recording of the conference call will be available on Neptune's website ( www.neptunebiotech.com ) shortly after the call.

Neptune's audited consolidated financial statements for the quarter ended May 31, 2013 and related MD&A will be made available on SEDAR at www.sedar.com , on EDGAR at www.sec.gov/edgar.shtml and on Neptune's website at http://www.neptunebiotech.com prior to the conference call.

About Neptune Technologies & Bioressources Inc.

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids (''PUFAs''). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune's products generally come in capsule form and serve as a dietary supplement to consumers.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,034.93 +208.63 1.17%
S&P 500 2,100.40 +19.22 0.92%
NASDAQ 4,994.6020 +62.7870 1.27%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs